陽明大學醫學士

   國立陽明交通大學內科學科教授

•    竹東榮民醫院內科住院醫師 
•    臺北榮民總醫院內科部住院總醫師
•    臺北榮民總醫院內科部心臟內科主治醫師

• 成人心臟內科
• 心臟超音波 Echocardiography
• 電氣生理 Electrocardiography

• 中華民國內科專科醫師
• 中華民國心臟專科醫師

• 中華民國內科醫學會
• 中華民國心臟學會
• 中華民國血脂及動脈硬化學會
• 中華民國重症醫學會

        wcyu@vghtpe.gov.tw

1. Chien Y, Chou SJ, Chang YL, Leu HB, Yang YP, Tsai PH, Lai YH, Chen KH, Chang WC, Sung SH and Yu WC. Inhibition of Arachidonate 12/15-Lipoxygenase Improves alpha-Galactosidase Efficacy in iPSC-Derived Cardiomyocytes from Fabry Patients. Int J Mol Sci. 2018;19(5):1480.
2. Huang WM, Lin YP, Chen CH and Yu WC. Tissue Doppler imaging predicts outcomes in hemodialysis patients with preserved left ventricular function. J Chin Med Assoc. 2019;82:351-355.
3. Wang WT, Sung SH, Liao JN, Hsu TR, Niu DM and Yu WC. Cardiac manifestations in patients with classical or cardiac subtype of Fabry disease. J Chin Med Assoc. 2020;83:825-829.
4. Lu DY, Huang WM, Wang WT, Hung SC, Sung SH, Chen CH, Yang YJ, Niu DM and Yu WC. Reduced global longitudinal strain as a marker for early detection of Fabry cardiomyopathy. Eur Heart J Cardiovasc Imaging. 2022;23:487-495.
5. Hung CL, Wu YW, Lin CC, Lai CH, Jyh-Ming Juang J, Chao TH, Kuo L, Sung KT, Wang CY, Wang CL, Chu CY, Yu WC and Hou CJ. 2021 TSOC Expert Consensus on the Clinical Features, Diagnosis, and Clinical Management of Cardiac Manifestations of Fabry Disease. Acta Cardiol Sin. 2021;37:337-354.

 限於篇幅,以上謹為代表著作